Advertisement
Research Article

Targeting COX-2/PGE2 Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation

  • Alessia Garufi,

    Affiliation: Department of Experimental Oncology, Molecular Oncogenesis Laboratory, Regina Elena National Cancer Institute, Rome, Italy

    X
  • Giuseppa Pistritto,

    Affiliation: Department of Neuroscience, Section of Pharmacology, University “Tor Vergata”, Rome, Italy

    X
  • Claudia Ceci,

    Affiliation: Department of Neuroscience, Section of Pharmacology, University “Tor Vergata”, Rome, Italy

    X
  • Livia Di Renzo,

    Affiliation: Department of Experimental Medicine, Institute Pasteur-Foundation Cenci Bolognetti, “Sapienza” University, Rome, Italy

    X
  • Roberta Santarelli,

    Affiliation: Department of Experimental Medicine, Institute Pasteur-Foundation Cenci Bolognetti, “Sapienza” University, Rome, Italy

    X
  • Alberto Faggioni,

    Affiliation: Department of Experimental Medicine, Institute Pasteur-Foundation Cenci Bolognetti, “Sapienza” University, Rome, Italy

    X
  • Mara Cirone mail,

    gdorazi@unich.it (GD); mara.cirone@uniroma1.it (MC)

    Affiliation: Department of Experimental Medicine, Institute Pasteur-Foundation Cenci Bolognetti, “Sapienza” University, Rome, Italy

    X
  • Gabriella D’Orazi mail

    gdorazi@unich.it (GD); mara.cirone@uniroma1.it (MC)

    Affiliations: Department of Experimental Oncology, Molecular Oncogenesis Laboratory, Regina Elena National Cancer Institute, Rome, Italy, Department of Medical, Oral and Biotechnological Sciences, University “G. d’Annunzio”, Chieti, Italy

    X
  • Published: November 07, 2012
  • DOI: 10.1371/journal.pone.0048342

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.